JumpStart Equity — 2021 Investments
1 investments dated 2021 · listed companies and verified rows first · show all
Vitranuvitranu.comOct 2021
Vitranu develops biomaterial and biologic technologies for ophthalmic applications, particularly focused on retinal and vitreoretinal diseases.
BiotechDeep TechHealthtechMedical DevicesColumbus, US
John Black(CEO)Katelyn Swindle-Reilly(Chief Technology Officer)Matthew Ohr(Chief Medical Officer)Joe Seiwert III(Chief Product Development Officer)Wayne Embree(Director)Brad Beasecker(Executive Officer)
Co-investorsJobsOhio Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.